The field of blood cancer therapeutics has seen enormous progression. Here, Steven Rosen, MD, from the City of Hope, Duarte, CA, gives an overview of the exciting trials and research being conducted in the field of hematological malignancies at the City of Hope. The center is home to facilities where CAR T-cell and stem cell trials are underway, and targeted small molecules are being produced and trialed, eliminating the need for support from pharmaceutical companies. At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France, Dr Rosen reflects upon the success of the studies that have taken place so far this year.
The challenging field of hem-onc therapeutics
